A型肉毒毒素延缓上面部皱纹的应用(3)
[15]Carruthers A，Carruthers J.Eyebrow height after botulinum toxin type A to the glabella[J].Dermatologic surgery，2007，33(1 Spec No.)：s26-s31.
[16]Wu Y，Zhao G，Li H，et al.Botulinum toxin type A for the treatment of glabellar lines in Chinese： a double-blind， randomized， placebo-controlled study[J].Dermatologic surgery ，2010，36(1)：102-108.
[17]Dulguerov N，D'Souza A.Update on treatment rationale and options for the ageing face[J].Current opinion in otolaryngology & head and neck surgery，2011，19(4)：269-275.
[18]Kerscher M，Roll S，Becker A，et al.Comparison of the spread of three botulinum toxin type A preparations[J].Archives of dermatological research，2012，304(2)：155-161.
[19]Fagien S，Carruthers JD.A comprehensive review of patient-reported satisfaction with botulinum toxin type a for aesthetic procedures[J].Plastic and reconstructive surgery，2008，122(6)：1915-1925.
[20]Beer K，Beer J.Overview of facial aging[J].Facial plastic surgery，2009，25(5)：281-284.
[21]Sepehr A，Chauhan N，Alexander AJ，et al.Botulinum toxin type a for facial rejuvenation： treatment evolution and patient satisfaction[J].Aesthetic plastic surgery，2010，34(5)：583-586.
[22]Nettar KD，Yu KC，Bapna S，et al.An internally controlled， double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA[J].Archives of facial plastic surgery，2011，13(6)：380-386.
[23]Ascher B，Talarico S，Cassuto D，et al.International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part I： Upper facial wrinkles[J].Journal of the European Academy of Dermatology and Venereology ，2010，24(11)：1278-1284.
[收稿日期]2012-06-01 [修回日期]2012-08-10
编辑/李阳利, http://www.100md.com(刘越)
[16]Wu Y，Zhao G，Li H，et al.Botulinum toxin type A for the treatment of glabellar lines in Chinese： a double-blind， randomized， placebo-controlled study[J].Dermatologic surgery ，2010，36(1)：102-108.
[17]Dulguerov N，D'Souza A.Update on treatment rationale and options for the ageing face[J].Current opinion in otolaryngology & head and neck surgery，2011，19(4)：269-275.
[18]Kerscher M，Roll S，Becker A，et al.Comparison of the spread of three botulinum toxin type A preparations[J].Archives of dermatological research，2012，304(2)：155-161.
[19]Fagien S，Carruthers JD.A comprehensive review of patient-reported satisfaction with botulinum toxin type a for aesthetic procedures[J].Plastic and reconstructive surgery，2008，122(6)：1915-1925.
[20]Beer K，Beer J.Overview of facial aging[J].Facial plastic surgery，2009，25(5)：281-284.
[21]Sepehr A，Chauhan N，Alexander AJ，et al.Botulinum toxin type a for facial rejuvenation： treatment evolution and patient satisfaction[J].Aesthetic plastic surgery，2010，34(5)：583-586.
[22]Nettar KD，Yu KC，Bapna S，et al.An internally controlled， double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA[J].Archives of facial plastic surgery，2011，13(6)：380-386.
[23]Ascher B，Talarico S，Cassuto D，et al.International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part I： Upper facial wrinkles[J].Journal of the European Academy of Dermatology and Venereology ，2010，24(11)：1278-1284.
[收稿日期]2012-06-01 [修回日期]2012-08-10
编辑/李阳利, http://www.100md.com(刘越)